AVAX
Atlas Venture Associates XI Portfolio holdings
AUM
$631M
1 Year Est. Return
–
AUM
$631M
AUM Growth
–
Holding
7
Top Buys
| 1 | +$466M | |
| 2 | +$87.9M | |
| 3 | +$27.2M | |
| 4 |
Spero Therapeutics
SPRO
|
+$26.7M |
| 5 |
Cogent Biosciences
COGT
|
+$10.3M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Communication Services | 74.99% |
| 2 | Healthcare | 25.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Skillz
SKLZ
$99M
| $466M | 73.8% |
+1,164,220
|
|
||
2
Intellia Therapeutics
NTLA
$1.41B
| $87.9M | 13.93% |
+1,615,321
|
|
||
|
SURF
3
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $27.2M | 4.31% |
+2,945,453
|
|
||
|
4
Spero Therapeutics
SPRO
$133M
| $26.7M | 4.23% |
+1,376,968
|
|
||
|
5
Cogent Biosciences
COGT
$2.22B
| $10.3M | 1.63% |
+916,196
|
|
||
6
Snap
SNAP
$13.2B
| $7.52M | 1.19% |
+150,160
|
|
||
7
Synlogic
SYBX
$19.8M
| $5.73M | 0.91% |
+176,798
|
|